Comparison of effect of BCG, glucan and levamisole on B16 melanoma metastases
- 1 February 1977
- journal article
- research article
- Published by Elsevier
- Vol. 13 (2) , 115-122
- https://doi.org/10.1016/0014-2964(77)90189-x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- RECOGNITION FACTORS AND NONSPECIFIC MACROPHAGE ACTIVATION IN THE TREATMENT OF NEOPLASTIC DISEASE*Annals of the New York Academy of Sciences, 1976
- Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: Studies on cell-mediated immunity and humoral antibody responsePublished by Elsevier ,1975
- Facilitation and inhibition of B16 melanoma by BCG in vivo and by lymphoid cells from BCG‐treated mice in vitroInternational Journal of Cancer, 1974
- BCG and CancerNew England Journal of Medicine, 1974
- BCG and CancerNew England Journal of Medicine, 1974
- Radioimmunoassay of Tumour Specific Transplantation Antigen of a Chemically Induced Rat Sarcoma: Circulating Soluble Tumour Antigen in Tumour BearersBritish Journal of Cancer, 1973
- BCG immunotherapy of local subcutaneous growths and post‐surgical pulmonary metastases of a transplanted rat epithelioma of spontaneous originInternational Journal of Cancer, 1973
- Levamisole Inhibits and Cures a Solid Malignant Tumour and its Pulmonary Metastases in MiceNature New Biology, 1972
- Immunotherapy Combined with Primary Resection of Murine FibrosarcomaAnnals of Surgery, 1972
- Facilitation of Rat Mammary Tumour Growth by BCGNature, 1970